1.       Amoli MM, Thomson W, Hajeer AH, et al. HLA-B35 association with nephritis in Henoch-Schönlein purpura. The Journal of Rheumatology. 2002; 29(5): 948-949.

2.       Amoli MM, Thomson W, Hajeer AH, et al. HLA-DRB1* 01 association with Henoch-Schönlein purpura in patients from northwest Spain. The Journal of Rheumatology. 2001; 28(6): 1266-1270.

3.       Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı ZS, et al. Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology. 2020; 59(6): 1372-1380. doi: 10.1093/rheumatology/kez410.

4.       Bastos JM, Medeiros J, Oliveira-Silva C, et al. IgA vasculitis presenting as pulmonary-renal syndrome. Cureus. 2025; 17(1): e77111. doi: 10.7759/cureus.77111. 

5.       Calvo-Río V, Hernández JL, Ortiz-Sanjuán F, et al. Relapses in patients with Henoch-Schönlein purpura: Analysis of 417 patients from a single center. Medicine. 2016; 95: e4217.  doi: 10.1097/MD.0000000000004217

6.       Castañeda S, Quiroga-Colina P, Floranes P, et al. IgA Vasculitis (Henoch-Schönlein Purpura): An Update on Treatment. J Clin Med. 2024; 13(21): 6621. doi: 10.3390/jcm13216621. 

7.       Çağlayan Ş, Çoban SB, Ulu K, et al. Gastrointestinal Involvement in Pediatric IgA Vasculitis: Clinical Features, Risk Factors, and Treatment Approach. Comprehensive Medicine. 2025; 17(1): 13-21. doi: 10.14744/cm.2024.09609

8.       Çakıcı EK, Gür G, Yazılıtaş F, et al. A retrospective analysis of children with Henoch–Schonlein purpura and re-evaluation of renal pathologies using Oxford classification. Clinical and Experimental Nephrology. 2019; 23(7): 939-947. doi: 10.1007/s10157-019-01726-5. Epub 2019 Mar 20.

9.       Davin JC, Forget P, Mahieu PR. Increased Intestinal Permeability to (51 Cr) EDTA Is Correlated with IgA Immune Complex‐Plasma Levels in Children with IgA‐Associated Nephropathies. Acta Pædiatrica. 1988; 77(1): 118-124. doi: 10.1111/j.1651-2227.1988.tb10609.x.

10.   Davin JC, Ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney international. 2001; 59(3): 823-834. doi: 10.1046/j.1523-1755.2001.059003823.x.

11.   Du L, Wang P, Liu C, et al. Multisystemic manifestations of IgA vasculitis. Clinical Rheumatology. 2021; 40(1): 43-52.  doi: 10.1007/s10067-020-05166-5.

12.   Ekinci RMK, Balci S, Bisgin A, et al. MEFV gene variants in children with Henoch-Schönlein purpura and association with clinical manifestations: A single-center Mediterranean experience. Postgraduate Medicine. 2019; 131(1): 68-72. doi: 10.1080/00325481.2019.1552479. 

13.   Gairdner D. The Schonlein-Henoch syndrome (anaphylactoid purpura). Q J Med. 1948; 17: 95–122.

14.   Gardner-Medwin JM, Dolezalova P, Cummins C, et al. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. The Lancet. 2002; 360(9341): 1197-1202. doi: 10.1016/S0140-6736(02)11279-7.

15.   Gu Y, Zhang Y, Zheng Z, Zhu P. Clinical characteristics and risk factors analysis of abdominal symptoms in IgA vasculitis patients: a retrospective cohort study. Clinical Rheumatology. 2025; 44(1): 349-356.  doi: 10.1007/s10067-024-07226-6.

16.   Guo Z, Li S, Liu C, et al. Immunoglobulin a vasculitis with central nervous system involvement: analysis of 10 cases. Clinical and Experimental Medicine. 2025;25(1): 145. doi: 10.1007/s10238-025-01679-y. 

17.   Hakim A. Concurrent Henoch-Schonlein purpura and papular-purpuric gloves-and-socks syndrome. Scand J Rheumatol. 2000; 29: 131–132. doi: 10.1080/030097400750001969.

18.   Hastings MC, Rizk DV, Kiryluk K, et al. IgA vasculitis with nephritis: Update of pathogenesis with clinical implications. Pediatr Nephrol. 2022; 37(4): 719–33. doi: 10.1007/s00467-021-04950-y. 

19.   Heineke MH, Ballering AV, Jamin A, et al. New insights in the pathogenesis of immunoglobulin a vasculitis (Henoch-Schönlein purpura). Autoimmun Rev. 2017; 16(12): 1246–53. doi: 10.1016/j.autrev.2017.10.009. 

20.   Jauhola O, Ronkainen J, Koskimies O, et al. Clinical course of extrarenal symptoms in Henoch–Schönlein purpura: a 6-month prospective study. Archives of disease in childhood. 2010; 95(11): 871-876. doi: 10.1136/adc.2009.167874.

21.   Jelusic M, Sestan M, Giani T, et al. New Insights and Challenges Associated with IgA Vasculitis and IgA Vasculitis With Nephritis—Is It Time to Change the Paradigm of the Most Common Systemic Vasculitis in Childhood? Front. Pediatr. 2022; 10: 853724. doi: 10.3389/fped.2022.853724. 

22.   Jennette JC, Falk RJ. Small-vessel vasculitis. New England Journal of Medicine. 1997; 337(21): 1512-1523. doi: 10.1056/NEJM199711203372106.

23.   Kaplan MM, Ekici Tekin Z, Çelikel E, et al. Characteristics of cutaneous manifestations in immunoglobulin a vasculitis and their relationships with system involvement and treatment needs. European Journal of Pediatrics. 2024; 184(1): 17. doi: 10.1007/s00431-024-05824-9.

24.   Kato S, Gold BD, Kato A. Gastrointestinal manifestations and pathogenesis in childhood immunoglobulin A vasculitis. Frontiers in Pediatrics. 2024; 12: 1459394. doi: 10.3389/fped.2024.1459394.

25.   Koskela M, Ylinen E, Ukonmaanaho EM, et al. The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch–Schönlein purpura nephritis. Pediatric Nephrology. 2017; 32(7): 1201-1209. doi: 10.1007/s00467-017-3608-5.

26.   López‐Mejías R, Genre F, Pérez BS, et al. Brief Report: Association of HLA–DRB1* 01 With IgA Vasculitis (Henoch‐Schönlein). Arthritis & Rheumatology. 2015; 67(3): 823-827. doi: 10.1002/art.38979. 

27.   Marcia M, Parodi E. Lumbar swelling and migrating edema in 3-and 4-year-old boys. SAGE Open Medical Case Reports. 2022; 10: 1-5. doi: 10.1177/2050313X221102112. 

28.   Mayer-Hain S, Gebhardt K, Neufeld M, et al. Systemic activation of neutrophils by immune complexes is critical to IgA vasculitis. The Journal of Immunology. 2022; 209(6): 1048-1058. doi: 10.4049/jimmunol.2100924.

29.   Oni L, Sampath S. Childhood IgA vasculitis (Henoch Schonlein purpura)—advances and knowledge gaps. Frontiers in pediatrics. 2019; 7: 257. doi: 10.3389/fped.2019.00257.

30.   Ozdogan H, Arisoy N, Kasapcapur O, et al. Vasculitis in familial Mediterranean fever. The Journal of rheumatology. 1997; 24(2): 323-327.

31.   Ozen S, Marks SD, Brogan P, et al. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis—the SHARE initiative. Rheumatology. 2019; 58(9): 1607-1616. doi: 10.1093/rheumatology/kez041.

32.   Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood  Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008 Part II: final classification criteria. Ann Rheum Dis. 2010; 69: 798–806. doi: 10.1136/ard.2009.116657.

33.   Parums DV. A review of IgA vasculitis (Henoch-Schönlein purpura) past, present, and future. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2024; 30: e943912. doi: 10.12659/MSM.943912.

34.   Peru H, Soylemezoglu O, Bakkaloglu SA, et al. Henoch Schonlein purpura in childhood: clinical analysis of 254 cases over a 3-year period. Clinical rheumatology. 2008; 27(9): 1087-1092.  doi: 10.1007/s10067-008-0868-2. 

35.   Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch–Schönlein): current state of knowledge. Current opinion in rheumatology. 2013; 25(2): 171-178. doi: 10.1097/BOR.0b013e32835d8e2a. 

36.   Piram M, Maldini C, Biscardi S, et al. Incidence of IgA vasculitis in children estimated by four-source capture–recapture analysis: a population-based study. Rheumatology. 2017; 56(8): 1358-1366. doi: 10.1093/rheumatology/kex158.

37.   Podraza Z, Poplicha K, Ufniarski T, et al. Laboratory Findings and Clinical Features in IgA Vasculitis: Identifying Predictors of Kidney Involvement and Disease Relapse in Pediatric Patients. Journal of Clinical Medicine. 2025; 14(9): 3055. doi: 10.3390/jcm14093055. 

38.   Reamy BV, Williams PM, Lindsay TJ. Henoch-Schonlein purpura. Am Fam Physician. 2009; 80(7): 697–704

39.   Rivas MN, Wakita D, Franklin MK, et al. Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation. Immunity. 2019; 51(3): 508-521. doi: 10.1016/j.immuni.2019.05.021.

40.   Rubino C, Monacelli C, Marrani E, et al. Gastrointestinal involvement in IgA vasculitis: a single-center 11-year study on a cohort of 118 children. Clinical rheumatology. 2021; 40(12): 5041-5046. doi: 10.1007/s10067-021-05863-9.

41.   Saulsbury FT. Clinical update: henoch-schönlein purpura. The Lancet. 2007; 369: 976-978. doi: 10.1016/S0140-6736(07)60474-7. 

42.   Sestan M, Kifer N, Sozeri, B, et al. Clinical features, treatment and outcome of pediatric patients with severe cutaneous manifestations in IgA vasculitis: Multicenter international study. Seminars in Arthritis and Rheumatism. 2023; 61: 152209. doi: 10.1016/j.semarthrit.2023.152209. 

43.   Sestan M, Srsen S, Kifer N, et al. Persistence and severity of cutaneous manifestations in IgA vasculitis is associated with development of IgA vasculitis nephritis in children. Dermatology. 2022; 238(2): 340-346. doi: 10.1159/000516765. 

44.   Shuai LJ, Zhang QY, Li XZ, et al. Guidelines for the diagnosis and management of childhood immunoglobulin A vasculitis. World Journal of Pediatrics. 2025; 21: 957-972. doi: 10.1007/s12519-025-00974-8. 

45.   Song Y, Huang X, Yu G, et al. Pathogenesis of IgA vasculitis: an up-to-date review. Frontiers in immunology. 2021; 12: 771619. doi: 10.3389/fimmu.2021.771619. 

46.   Stone HK, Mitsnefes M, Dickinson K, et al. Clinical course and management of children with IgA vasculitis with nephritis. Pediatric Nephrology. 2023; 38(11): 3721-3733.  doi: 10.1007/s00467-023-06023-8. 

47.   Sunar Yayla EN, Bakkaloğlu SA. Clinical features of paediatric immunoglobulin A vasculitis patients with scrotal involvement. Modern Rheumatology. 2023; 33(5): 1016-1020. doi: 10.1093/mr/roac111. 

48.   Wang L. Endoscopic features and treatment of Henoch-Schonlein purpura in children. Journal of Clinical Pediatrics. 2017; 12: 946-948.

49.   Xu L, Li Y, Wu X. IgA vasculitis update: epidemiology, pathogenesis, and biomarkers. Frontiers in Immunology. 2022; 13: 921864. doi: 10.3389/fimmu.2022.921864.

50.   Yang YH, Wang SJ, Chuang YH, Lin YT, Chiang BL. The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF alpha treatment in children with Henoch-Schönlein purpura. Clin Exp Immunol. 2002; 130(2):352–7. doi: 10.1046/j.1365-2249.2002.01964.x.